Follow the Surgical Science Sweden AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Surgical Science Sweden AB has logged 6 insider filings. Market capitalisation: €1.6bn. The latest transaction was disclosed on 23 June 2026 (Purchase). Among the most active insiders: Anna Ahlberg. Every trade is openly available.
6
Insider Decl.
0
Thresholds
€400,584
6 ops.
Buy Volume
·
0 ops.
Sell Volume
35Σ signal
Buys €400,584· Sells
Fundamental score
Ranked 7,444 of 25,927 companies
62.2
score / 100
Value
60
Quality
64
FCF yld2.0%
Earn yld4.4%
EV/EBITDA8.3x
ROE1.2%
Gross mgn66%
Net mgn6.7%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6,000 shares@ €3.29360.0012% mcap67.8% of flowTeckningsoptionFI:A003Q216-1
Ideal exit: 21 Mar 2026 (T+270)
6 of 6 declarations
About Surgical Science Sweden AB
Surgical Science Sweden AB is a company focused on developing surgical simulation solutions. It aims to enhance the training of healthcare professionals through innovative technologies.